Helping you lead the way in high-performance immunoassays and analytical platforms for precision in vitro diagnostics.
Advancements in materials science, miniaturization, and scalable manufacturing are redefining the design and deployment of immunoassays. Nanoparticle-enabled assays are improving analytical sensitivity for low-abundance analytes. To support high-throughput laboratory workflows, assay consumables integrate seamless automation. Plastic consumables are evolving into functional microfluidic systems that allow for multiplexing and reduced sample and reagent volumes.
In parallel, sustainability is gaining importance in assay consumable design, with growing exploration of recyclable and biodegradable polymers for single-use formats.
Backed by decades of experience, Syrma Johari MedTech helps in vitro diagnostic (IVD) companies drive successful innovation in high-sensitivity immunoassay platforms. Our strength lies in our deep technical know-how and advanced tools and technologies that deliver custom assay formats and multiplex platforms with reproducibility at scale.
We seamlessly integrate our solutions to translate your concepts into market-ready immunoassay devices. With comprehensive capabilities in design, manufacturing, and regulatory support, we reduce time to market and sustain market competitiveness for your product.
As an ISO 13485–certified medical device CDMO, our robust quality systems comply with MDSAP, U.S. FDA, and other international regulations for smoother market entry.
Beyond Functionality: Engineering Regulatory Resilience into Next-Gen IVD Platforms
Streamline your immunoassay product journey from concept to commercialization with our unmatched technical expertise and advanced technologies.
LEGAL
CONTACT US
Business Inquiry
© 2026, Syrma Johari MedTech Ltd. All rights reserved.